News

MANNING & NAPIER ADVISORS LLC has opened a new $72.0M position in $DHR, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 03-31-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $DHR.

$DHR Hedge Fund Activity

We have seen 857 institutional investors add shares of $DHR stock to their portfolio, and 1,168 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 3,601,092 shares (-91.9%) from their portfolio in Q4 2024, for an estimated $826,630,668
• FMR LLC removed 3,097,352 shares (-13.1%) from their portfolio in Q4 2024, for an estimated $710,997,151
• D. E. SHAW & CO., INC. added 2,109,520 shares (+40977.5%) to their portfolio in Q4 2024, for an estimated $484,240,316
• WELLINGTON MANAGEMENT GROUP LLP removed 1,987,430 shares (-8.5%) from their portfolio in Q4 2024, for an estimated $456,214,556
• LEGAL & GENERAL GROUP PLC removed 1,636,980 shares (-28.1%) from their portfolio in Q4 2024, for an estimated $375,768,759
• TWO SIGMA ADVISERS, LP added 1,601,800 shares (+4248.8%) to their portfolio in Q4 2024, for an estimated $367,693,190
• CAPITAL WORLD INVESTORS added 1,566,658 shares (+32.7%) to their portfolio in Q4 2024, for an estimated $359,626,343

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$DHR Insider Trading Activity

$DHR insiders have traded $DHR stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $DHR stock by insiders over the last 6 months:

• DANIEL RASKAS (SVP - Corporate Development) has made 0 purchases and 2 sales selling 34,688 shares for an estimated $8,218,556.
• BRIAN W ELLIS (Senior Vice President - GC) sold 5,700 shares for an estimated $1,277,541
• ALAN G SPOON sold 550 shares for an estimated $113,553

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$DHR Government Contracts

We have seen $177,924,990 of award payments to $DHR over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• OTA - PANDEMIC PREPAREDNESS AND RESPONSE: ESTABLISHING A PLATFORM FOR DIAGNOSIS AND SURVEILLANCE OF EMERGIN...: $31,926,876
• POLYMERASE CHAIN REACTION (PCR) DIAGNOSTIC TESTING FOR VISN 2 DOWNSTATE: $3,781,390
• MOLECULAR DIAGNOSTIC TESTS FOR SARS-COV-2: $3,223,145
• IN-VITRO REAGENTS: $3,088,148
• CEPHEID MOLECULAR TESTING: $2,992,273

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

$DHR Congressional Stock Trading

Members of Congress have traded $DHR stock 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $DHR stock by members of Congress over the last 6 months:

• REPRESENTATIVE GREG LANDSMAN sold up to $15,000 on 03/27.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 02/26.
• REPRESENTATIVE ROBERT BRESNAHAN sold up to $50,000 on 02/25.
• SENATOR MARKWAYNE MULLIN sold up to $50,000 on 02/13.
• REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 01/15.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$DHR Analyst Ratings

Wall Street analysts have issued reports on $DHR in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Citigroup issued a "Buy" rating on 04/07/2025
• Guggenheim issued a "Buy" rating on 12/19/2024

To track analyst ratings and price targets for $DHR, check out Quiver Quantitative's $DHR forecast page.

$DHR Price Targets

Multiple analysts have issued price targets for $DHR recently. We have seen 5 analysts offer price targets for $DHR in the last 6 months, with a median target of $260.0.

Here are some recent targets:

• Catherine Ramsey Schulte from Robert W. Baird set a target price of $231.0 on 04/16/2025
• An analyst from Stifel Nicolaus set a target price of $260.0 on 03/14/2025
• Matthew Sykes from Goldman Sachs set a target price of $250.0 on 01/15/2025
• Subbu Nambi from Guggenheim set a target price of $275.0 on 12/19/2024
• Doug Schenkel from Wolfe Research set a target price of $285.0 on 10/31/2024

Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.

Check out Quiver Quantitative's $DHR ticker page for more data.

This article was originally published on Quiver News, read the full story.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.